1022955-07-2

Upstream product

• 1953-54-4 indol-5-ol 
• 1022951-80-9 2-methyl-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022951-77-4 4-{[(2-hydroxy-ethyl)-methyI-amino]-methyl}-1H-indol-5-ol 
• 1022953-76-9 8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022951-83-2 2-methyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022954-96-6 tert-butyl 10-chloro-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole-2-carboxylate 
• 56542-67-7 3-cyanobenzene sulfonyl chloride 
• 1022953-79-2 tert-butyl 8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole-2-carboxylate 
• 1022955-00-5 tert-butyl 10-chloro-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole-2-carboxylate 

Relevant academic research and scientific papers

8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4] OXAZEPINO [6, 7-E] INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS

The present invention relates to compounds of the formula (I) wherein A, X and R1 to R9 are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT6 receptor-related disorders.